Showing results (2891-2900 of 8,932) with videos related to

Sort By:
Pageof 894
BJU International|June 3, 2011
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)J Curtis Nickel, Peter Gilling, Teuvo L Tammela, et al.
BJU International|June 3, 2011
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinomaRicardo L Favaretto, Shahrokh F Shariat, Caroline Savage, et al.
BJU International|May 21, 2011
Age at surgery, educational level and long-term urinary incontinence after radical prostatectomyAndreas E Nilsson, Martin C Schumacher, Eva Johansson, et al.
BJU International|May 21, 2011
Near-infrared tissue oximetry and digital image analysis: quantification of renal ischaemia in real time during partial nephrectomyArthur A Caire, Xavier Alvarez, Sarah Conley, et al.
BJU International|November 26, 2010
Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expressionRamy Youssef, Payal Kapur, Wareef Kabbani, et al.
BJU International|November 26, 2010
Preferences for antimuscarinic therapy for overactive bladderPaul Swinburn, Andrew Lloyd, Shehzad Ali, et al.
BJU International|November 26, 2010
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)Emil Scosyrev, Benjamin W Ely, Edward M Messing, et al.
BJU International|October 7, 2009
Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 yearsChung Cheng Wang, Michael B Chancellor, Jyh Ming Lin, et al.
BJU International|January 7, 2011
Therapeutic potential of purinergic signalling for diseases of the urinary tractGeoffrey Burnstock
BJU International|December 21, 2010
Vasoactive intestinal polypeptide, an erectile neurotransmitter, improves erectile function more significantly in castrated rats than in normal ratsMin-Guang Zhang, Zhou-Jun Shen, Cun-Ming Zhang, et al.
Pageof 894